Blogs

RARE Advocacy Exchange Session 7, Getting a Precise Genetic Diagnosis

September 30, 2025

This session recording is from Sept.  18, 2025

 Rare Advocacy Exchange Session 7:

Getting A Precise Diagnosis is Critical for Adults & Children

Overview

This session explored why a timely and accurate molecular diagnosis is transformative for rare disease patients and families. It highlighted how genetic testing is reshaping research, treatment, and family care. A precise genetic diagnosis is not just a label: it is a gateway to clarity, community, and care. The panel emphasized both the breakthroughs (AI platforms, expanding guidelines, gene-based therapies) and the barriers (misconceptions, inequities, lack of clinician education, insurer resistance) in shortening the diagnostic odyssey.

Opening Remarks
Cody Barnett, Patient Advocacy – United States, Canada, & Latin America at Illumina.

Moderated by
Effie Parks (Once Upon a Gene podcast, CTNNB1 mom)

Panelists
Lukas Lange (CEO, Probably Genetic),
Dr. Pranav Garimella (American Kidney Fund),  
Dr. Michael Kruer (Phoenix Children’s/University of Arizona) 


Top Takeaways

  • Diagnosis = Lifeline — Beyond naming a disease, a genetic diagnosis informs treatment options, clinical trial eligibility, prognosis, and family planning.
  • Umbrella labels are not enough. Terms like “chronic kidney disease,” “cerebral palsy,” or “autism” are descriptive, not explanatory. Digging into the why is crucial.
  • AI is reshaping access. Platforms like Probably Genetic use patient-driven data, AI, and telehealth to close diagnostic gaps.
  • Data privacy matters. Patient consent, opt-in recontact, and de-identified data sharing build trust and enable long-term value.
  • Equity gaps persist. Communities of color (e.g., APOL1-linked kidney disease in Black populations) are disproportionately impacted but under-tested.
  • Telemedicine + counseling = access. Genetic tests alone aren’t enough; patients need interpretation, counseling, and guidance.
  • Patient advocates drive change. Families often educate their own providers, spread awareness, and accelerate adoption of testing.
  • Reclassification of variants (VUS) is ongoing. Many uncertainties today may be clarified tomorrow; repeat or updated testing can bring answers.
  • Cross-pollination between umbrella and rare groups strengthens research infrastructure, natural history studies, and trial readiness.
  • The future is near. With AI and large-scale initiatives (e.g., NIH’s RAPID program), the panel envisioned eliminating the “diagnostic odyssey” within five years.

Considerations for Advocates & Community

  • Equip families to ask for genetic testing when confronted with ambiguous diagnoses.
  • Educate primary care providers and specialists about when and how to order testing.
  • Advocate for coverage of WES/WGS as first-tier diagnostics.
  • Build bridges between rare condition-specific groups and umbrella communities (autism, CP, kidney disease) to leverage shared tools and outcome measures.
  • Push for equitable access—testing programs must reach underserved, rural, and minority communities.
  • Encourage clinicians to revisit old tests, re-check VUS classifications, and stay current with evolving guidelines.

Useful Resources

Questions Posed & Key Answers

Should all CP or CKD patients get genetic testing?
CP: Likely yes, as genetics often outweighs presumed birth injury. CKD: Strongly recommended in younger patients, those with family history, or atypical presentation.
Can Primary Care Providers order WGS?
Yes, but comfort and reimbursement vary. Telehealth services like Genome Medical may help.
What about re-testing after 10 years?
Yes, technology and classification have advanced significantly.
How to handle Variant of Uncertain Significance ( VUS ) results?
Revisit results regularly; ~75% of VUSs are eventually reclassified as benign. AI and phenotype tools are helping refine classifications.
How can we expand access in communities of color?
Patient voices + advocacy education are key; providers must recognize genetic predispositions like APOL1.

Great Quotes & One-Liners

  • “A diagnosis isn’t the end. It’s the beginning.” – Cody Barnett
  • “Chronic kidney disease is like saying you have a fever. It’s not a diagnosis—it’s a symptom.” – Dr. Garimella
  • “Umbrella (diagnosis) labels help, but we must always ask: why?” – Dr. Kruer
  • “AI can be the Harry Potter sorting hat—matching families to the right diagnosis and community.” – Lukas
  • “If you got a genetic test done, tell your doctor. They might test the next patient—and that changes everything.” – Lukas
  • “You won’t find a patient with breast cancer today who hasn’t had genetic testing. Rare disease needs to catch up.” – Dr. Garimella
  • “Five years from now, I want to see the diagnostic odyssey gone.” – Lukas
  • “We may only have treatments for 5% of rare diseases, but diagnosis builds the case for the 95% still waiting.” – Panel consensus

Stay Connected

Sign up for updates straight to your inbox.

FacebookTwitterInstagramYoutube